Skip to content
‹ Back to IndustriesSciences

Virgin Galactic Test Flight Reaches Space From New Mexico

(Bloomberg) — Virgin Galactic Holdings Inc. flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company. The VSS Unity test flight from New Mexico on Saturday helps put the company back…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Sir Richard BransonSpaceTest FlightVirgin Galactic
Share
Virgin Galactic Test Flight Reaches Space From New Mexico

Key takeaways

01

(Bloomberg) — Virgin Galactic Holdings Inc.

02

flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company.

03

The VSS Unity test flight from New Mexico on Saturday helps put the company back…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

(Bloomberg) —

Virgin Galactic Holdings Inc. flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company.

The VSS Unity test flight from New Mexico on Saturday helps put the company back on its stated schedule of flying company founder Richard Branson to suborbital space as early as this summer, and resuming ticket sales.

Branson and Chief Executive Officer Michael Colglazier observed the flight from Virgin Galactic’s operations center at Spaceport America, near Truth or Consequences, New Mexico.

@virgingalactic #UNITY21 pic.twitter.com/c6k4A3H89I
— Richard Branson (@richardbranson) May 22, 2021

“It was a very, very clean and elegant flight,” Colglazier said Saturday in a telephone interview, calling the test a success that met each objective, including the first trip with a new, more precise flight control system to improve the spacecraft’s handling.

The unexpected part of the event, he said, was when an ecstatic Branson sprayed him with champagne following the flight. “That was unusual and not expected,” Colglazier said.

Piloted by CJ Sturckow and Dave Mackay, the VSS Unity flight was the company’s first to space from New Mexico, which became the third U.S. state from which people have flown to space after Florida and California. A 1982 Space Shuttle mission landed at White Sands Missile Range in New Mexico.

VSS Unity was traveling at a speed of Mach 3 after being released from the mothership, VMS Eve, and reached space at an altitude of 55.45 miles (89.2 kilometers), before landing at Spaceport America, according to a statement.

The flight was the company’s first rocket burn since February 2019, when Beth Moses, a Virgin engineer and astronaut instructor, joined a test flight from Mojave, California. The trip paves the way for Virgin’s next test flight, which is expected to carry additional employees as the company prepares for its commercial service.

The company isn’t ready to say when it will be ready for the next test flight with four employees. “You can imagine I’m getting a lot of people pinging me with ‘I’d like to be on,’” Colglazier said.

After the 2019 flight engineers discovered hull damage on the spacecraft from air pressure that had built up after ventilating holes were accidentally covered, according to “Test Gods,” a book published this month by New Yorker writer Nicholas Schmidle, who was given access to observe the company for several years.

Amid delays caused by the pandemic, with many employees working from home, Virgin Galactic’s testing program suffered another setback in December when VSS Unity dropped from its carrier aircraft but the rocket motor failed to ignite. The craft glided back to Spaceport America and landed without incident.

A second flight attempt in February was scuttled by electrical interference detected in the spacecraft’s avionics system. The company spent about two months repairing the interference issues, which engineers traced to the installation of a more powerful flight computer last year.

Earlier this month, Virgin Galactic warned investors that it was reviewing “fatigue and stress” issues in its four-engine carrier aircraft, VMS Eve. The airplane was cleared to fly after “a detailed inspection and thorough analysis,” the company said Thursday.

—

By Justin Bachman

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

PharmaLogic buys Lantheus' New Jersey radiopharma plant with a supply deal attached

PharmaLogic buys Lantheus' New Jersey radiopharma plant with a supply deal attached

PharmaLogic is buying Lantheus' contract manufacturing unit and Springfield, New Jersey radiopharmaceutical plant, plus a long-term deal to make lutetium Lu 177 dotatate for Lantheus. Radioligand developers looking for capacity should ask how much of the plant's capacity is still open.

  • 01A long-term supply contract attached to a plant sale could help keep costly hot-cell capacity in use. According to Grand View Research, committed supply agreements are among the tools that help providers align capital spending with customer development milestones.
  • 02Radioligand developers evaluating PharmaLogic's Agilera unit should ask how much Springfield capacity the lutetium Lu 177 dotatate contract will take up and how much is left for new programs.
  • 03Two pending transactions shape what to watch next: regulatory review and closing conditions for the PharmaLogic purchase, and Curium’s August offer of upward of $8 billion for Lantheus, which is still closing.

Nov 18, 2026

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA agreed to buy Rapid Micro Biosystems, maker of the Growth Direct microbial testing platform, for $0.75 per share in cash. The deal turns a 2025 distribution partnership into ownership. Growth Direct instruments, consumables and software would then come from the company that already sells QC products to pharma labs, pending a December 2026 close.

  • 01Growth Direct shifts from a Merck-distributed product, under a February 2025 agreement, to a Merck-owned one inside a QC portfolio that spans environmental monitoring, in-process and release testing.
  • 02For labs that already run Growth Direct alongside MilliporeSigma QC products, the useful question is how the platform's digital sample records will connect to the rest of that workflow after close.
  • 03The next date to watch is the Schedule TO filing that opens the tender offer; closing targeted for December 2026 requires a majority of Rapid Micro’s voting shares to be tendered.

Nov 17, 2026

SR-Tiget gene therapy families average six months in Milan, with years of follow-up testing

SR-Tiget gene therapy families average six months in Milan, with years of follow-up testing

Gene therapy at Milan’s SR-Tiget includes a family support programme that helps relatives manage months-long stays (often around six months) for treatment, while a regulated lab can track patient samples for up to 20 years. Follow-up visits can outnumber new treatments, adding to the long-term workload.

  • 01In 2025, the programme logged 133 follow-up visits against 17 treatments; with roughly 15 years of twice-yearly checkups per patient, the follow-up load is likely to keep growing even if new treatments stay flat.
  • 02At SR-Tiget, the average family spends six months in Milan, and the child's samples can keep reaching the lab for as long as twenty years.
  • 03A practical question for gene therapy services: who alerts the lab when a child’s fever delays a blood draw? At SR-Tiget, research nurses manage the patient schedule and coordinate sample timing with the lab.

Nov 16, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512